<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03297437</url>
  </required_header>
  <id_info>
    <org_study_id>PsychiatricUHZPUK</org_study_id>
    <nct_id>NCT03297437</nct_id>
  </id_info>
  <brief_title>Predictors for Successful Neurofeedback Training</brief_title>
  <acronym>Predictors</acronym>
  <official_title>Predictors for Successful Neurofeedback Training</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Frank Scharnowski</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Psychiatric University Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to identify predictors of neurofeedback training&#xD;
      success.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last decades, neurofeedback has been established as a promising scientific tool.&#xD;
      Learning voluntary control over their own brain activity allows for establishing causal links&#xD;
      between brain activity and mental functions. However, patients participants differ in their&#xD;
      ability to learn control over their own brain activity with neurofeedback. It is thus crucial&#xD;
      to understand why some participants are more successful in regulating their own brain&#xD;
      activity than others. The objective of the present study is thus to identify predictors for&#xD;
      successful learning self-regulation with real-time fMRI neurofeedback. To achieve this goal,&#xD;
      we will evaluate the introspection ability of healthy participants using standardized&#xD;
      psychological questionnaires and tasks. These scores will then be correlated with how well&#xD;
      they learned self-regulation skills using established real-time fMRI neurofeedback protocols.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between introspection scores and learning success</measure>
    <time_frame>48 months</time_frame>
    <description>The primary outcome measure is a correlation between introspection scores and neurofeedback learning success across all subjects.</description>
  </primary_outcome>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurofeedback training</intervention_name>
    <description>In a neurofeedback setting, brain activity is measured non-invasively, the brain imaging data is analyzed in real-time, and then feedback regarding the current level of brain activity is provided to the subject.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 18 - 65 years. Magnetic resonance imaging compatibility.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Physical or psychiatric disorders (DSM-V diagnosis). Current substance abuse. Exclusion&#xD;
        criteria applicable to MRI (metallic implants, claustrophobia, epilepsy).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frank Scharnowski, Prof. Dr.</last_name>
    <phone>+41443842953</phone>
    <email>Frank.Scharnowski@uzh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of Psychiatry, University of Zurich</name>
      <address>
        <city>Zürich</city>
        <state>Zürich-</state>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Scharnowski, Prof. Dr.</last_name>
      <phone>+41443842953</phone>
      <email>Frank.Scharnowski@uzh.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ronald Sladky, PD Dr.</last_name>
      <phone>+41443842667</phone>
      <email>ronald.sladky@uzh.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>September 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2017</study_first_posted>
  <last_update_submitted>September 28, 2017</last_update_submitted>
  <last_update_submitted_qc>September 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Psychiatric University Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Frank Scharnowski</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

